Active-ingredient Dossier
Rizatriptan Benzoate
Active-ingredient Dossier for Rizatriptan Benzoate (triptan). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: RIXALT
- Brand: RIZATRIPTAN
- Brand: APO-RIZATRIPTAN
- Brand: MAXALT
- Brand: MAXATAN
- Brand: Rizatriptan ODT Viatris
- Therapeutic area: Neurology
What is
Rizatriptan Benzoate Rizatriptan Benzoate is a triptan. It is used in the treatment of migraine and related neurological conditions.
Australian brands containing
Rizatriptan Benzoate — RIZATRIPTAN — APO-RIZATRIPTAN — MAXALT — MAXATAN — RIXALT — Rizatriptan ODT Viatris — RIZATRIPTAN-AU — GPPL
Therapeutic areas
Rizatriptan Benzoate is registered in neurology, with 10 brands containing this ingredient on the ARTG.
Sponsor landscape
The ingredient is marketed by five sponsors: Arrotex Pharmaceuticals, Organon Pharma, GM Pharma, Medis Pharma, and Medsurge Pharma.
PBS and regulatory activity
The latest PBAC outcome on record is from November 2009, with one brand having a PBAC outcome documented. No AusPARs are currently on record for this ingredient.